AI-generated analysis. Always verify with the original filing.
Apyx Medical Corporation filed an 8-K on March 10, 2026, under Item 2.02 disclosing results of operations via Exhibit 99.1 earnings press release. The filing includes Item 9.01 referencing the press release and cover page interactive data file.
Event Type
Disclosure
Mandatory
Variant
8-K
of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any f
Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Earnings press release dated March 10, 2026 104 Cover Page Interactive Data File (e